IMDAILM: Inferring miRNA-Disease Association by Integrating lncRNA and miRNA Data

In recent years, more and more studies have shown that microRNAs (miRNAs) play a key role in many important biological processes. Dysregulation of miRNAs can lead to a variety of diseases like cancers, thus predicting potential miRNA-disease associations is important for understanding drug development and disease pathogenesis, diagnosis and treatment. It is known that experimental methods to validate miRNA-disease associations typically involve miRNA knockout or knockdown, which is time and labor-intensive. As a result, computational models have been developed to predict unknown miRNA-disease associations from available information related to miRNAs, diseases, genes, and so on. However, their performances are yet to be improved. Noticing that appropriately combining multiple data-source is usually helpful for improving prediction accuracy, we have developed IMDAILM: Inferring miRNA-Disease Association by integrating lncRNA and miRNA data, a low-rank matrix completion model integrating miRNA, long noncoding RNA (lncRNA) and disease information to predict miRNA-disease associations. Specifically, the miRNA-disease association network and the lncRNA-disease association network are fused to form a new heterogeneous network consisting of 3 types of nodes representing miRNAs, lncRNAs and diseases. In addition, a negative sample inference method was proposed to infer unrelated miRNA-disease pairs. Based on both heterogeneous network and negative samples, a low-rank matrix completion model is proposed and solved. In practice, IMDAILM achieved an area under the curve (AUC) of 0.8884 for predicting miRNAs associated with diseases under the 5-fold cross-validation (CV), outperforming a few recent methods. IMDAILM also yielded an AUC of 0.8870 for predicting both lncRNAs and miRNAs associated with diseases. In addition, the 5-fold CV results indicate that IMDAILM is also superior to other methods in predicting miRNAs associated with isolated diseases. Finally, we confirmed a few novel predicted miRNAs associated with specific diseases like lung cancers by literature mining. In summary, the integration of lncRNA information into a matrix completion framework contributes to the prediction of miRNA-disease associations.

[1]  Xiangxiang Zeng,et al.  Prediction and Validation of Disease Genes Using HeteSim Scores , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[2]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[3]  X. Yang,et al.  Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer. , 2016, European review for medical and pharmacological sciences.

[4]  M. Zheng,et al.  Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer , 2014, Archives of Gynecology and Obstetrics.

[5]  S. Brenner,et al.  General Nature of the Genetic Code for Proteins , 1961, Nature.

[6]  Yu Wang,et al.  MiR-195 suppresses non-small cell lung cancer by targeting CHEK1 , 2015, Oncotarget.

[7]  Jing Liu,et al.  Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Ning Liu,et al.  Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675 , 2014, PloS one.

[9]  Michael W Sill,et al.  Improved survival with bevacizumab in advanced cervical cancer. , 2014, The New England journal of medicine.

[10]  Xia Li,et al.  Prediction of potential disease-associated microRNAs based on random walk , 2015, Bioinform..

[11]  Alan D. Lopez,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.

[12]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[13]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[14]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[15]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[16]  Lynne T. Bemis,et al.  Truncation in CCND 1 mRNA alters miR-16-1 regulation in mantle cell lymphoma , 2008 .

[17]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[18]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[19]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[20]  Jun Zhang,et al.  Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21 , 2016, Cancer biology & therapy.

[21]  Cheng Liang,et al.  A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..

[22]  William A Robinson,et al.  Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.

[23]  T. Kwok,et al.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.

[24]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[25]  L. Lefebvre,et al.  Brains, Lifestyles and Cognition: Are There General Trends? , 2008, Brain, Behavior and Evolution.

[26]  Keqin Li,et al.  Network Consistency Projection for Human miRNA-Disease Associations Inference , 2016, Scientific Reports.

[27]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[28]  G. Bhanot,et al.  Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.

[29]  Peter S Linsley,et al.  MicroRNAs and Cell Cycle Regulation , 2007, Cell cycle.

[30]  C. Pasquier,et al.  Prediction of miRNA-disease associations with a vector space model , 2016, Scientific Reports.

[31]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[32]  C. Yanofsky Establishing the Triplet Nature of the Genetic Code , 2007, Cell.

[33]  Vildan Bozok Çetintaş,et al.  miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells , 2016, Tumor Biology.

[34]  Yan Zhao,et al.  ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction , 2018, RNA biology.

[35]  T. Kwok,et al.  The miR-18 a microRNA functions as a potential tumor suppressor by targeting on KRas , 2009 .

[36]  Ming Sun,et al.  Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression , 2014, Molecular Cancer Therapeutics.

[37]  Yan Zhang,et al.  Prediction of Disease-related microRNAs through Integrating Attributes of microRNA Nodes and Multiple Kinds of Connecting Edges , 2019, Molecules.

[38]  Jing Wang,et al.  Progress in the application of molecular biomarkers in gliomas. , 2015, Biochemical and biophysical research communications.

[39]  Yu Li,et al.  MicroRNAs in Common Human Diseases , 2012, Genom. Proteom. Bioinform..

[40]  George M Yousef,et al.  Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. , 2010, Clinical biochemistry.

[41]  Martin Reczko,et al.  DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs , 2012, Nucleic Acids Res..

[42]  Xing Chen,et al.  Ensemble of decision tree reveals potential miRNA-disease associations , 2019, PLoS Comput. Biol..

[43]  V. Ambros MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[44]  Yadong Wang,et al.  Predicting human microRNA-disease associations based on support vector machine , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[45]  Helen Wheeler,et al.  Antiangiogenic therapy for high-grade glioma. , 2014, The Cochrane database of systematic reviews.

[46]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[47]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[48]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[49]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[50]  Hailin Chen,et al.  Prediction of Associations between OMIM Diseases and MicroRNAs by Random Walk on OMIM Disease Similarity Network , 2013, TheScientificWorldJournal.

[51]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.